Target Details
| UniProt AC | P05771 |
|---|---|
| Gene Symbol | PRKCB |
| Protein Name | Protein kinase C beta type |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00130 (C1_1) PF00168 (C2) PF00069 (Pkinase) PF00433 (Pkinase_C) |
Summary
- Multi-target molecules 457
- Clinical molecules 133
- Avg pChEMBL 7.4
KEGG Pathways (73)
- AGE-RAGE signaling pathway in diabetic complications
- African trypanosomiasis
- Aldosterone synthesis and secretion
- Aldosterone-regulated sodium reabsorption
- Amoebiasis
- Amphetamine addiction
- B cell receptor signaling pathway
- Calcium signaling pathway
- Carbohydrate digestion and absorption
- Chemical carcinogenesis - receptor activation
- Chemokine signaling pathway
- Choline metabolism in cancer
- Cholinergic synapse
- Circadian entrainment
- Coronavirus disease - COVID-19
- Diabetic cardiomyopathy
- Dopaminergic synapse
- EGFR tyrosine kinase inhibitor resistance
- Endocrine and other factor-regulated calcium reabsorption
- ErbB signaling pathway
- Fc gamma R-mediated phagocytosis
- Focal adhesion
- GABAergic synapse
- Gap junction
- Gastric acid secretion
- Glioma
- Glutamatergic synapse
- GnRH secretion
- GnRH signaling pathway
- Growth hormone synthesis, secretion and action
- HIF-1 signaling pathway
- Hepatitis B
- Hepatocellular carcinoma
- Human cytomegalovirus infection
- Human immunodeficiency virus 1 infection
- IgSF CAM signaling
- Inflammatory mediator regulation of TRP channels
- Influenza A
- Insulin resistance
- Insulin secretion
- Leishmaniasis
- Leukocyte transendothelial migration
- Long-term depression
- Long-term potentiation
- MAPK signaling pathway
- Melanogenesis
- MicroRNAs in cancer
- Morphine addiction
- NF-kappa B signaling pathway
- Natural killer cell mediated cytotoxicity
- Neuroactive ligand signaling
- Neutrophil extracellular trap formation
- Non-small cell lung cancer
- Oxytocin signaling pathway
- Pancreatic secretion
- Parathyroid hormone synthesis, secretion and action
- Pathways in cancer
- Pathways of neurodegeneration - multiple diseases
- Phosphatidylinositol signaling system
- Proteoglycans in cancer
- Rap1 signaling pathway
- Ras signaling pathway
- Retrograde endocannabinoid signaling
- Salivary secretion
- Serotonergic synapse
- Sphingolipid signaling pathway
- Spinocerebellar ataxia
- Thyroid hormone signaling pathway
- Thyroid hormone synthesis
- VEGF signaling pathway
- Vascular smooth muscle contraction
- Wnt signaling pathway
- mTOR signaling pathway
Active Molecules (457)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
CNPLEVGVGWVFGT
|
6.6 | IC50 | 2 | — | |
KOZFSFOOLUUIGY
|
6.6 | IC50 | 26 | — | |
SSZFVGXDYBMVDD
|
6.6 | IC50 | 12 | Yes | |
KTTKZYWEKGBVIX
|
6.6 | IC50 | 3 | — | |
PBCZSGKMGDDXIJ
|
6.6 | IC50 | 12 | Yes | |
DKHPQQRGPHOKBV
|
6.6 | IC50 | 2 | — | |
KTTKZYWEKGBVIX
|
6.6 | IC50 | 3 | — | |
LAOIBIIMKUINJL
|
6.6 | IC50 | 12 | Yes | |
XWKJUHBICAMYNW
|
6.6 | Ki | 6 | — | |
IXOVKVHWGKDXKQ
|
6.6 | IC50 | 12 | Yes | |
RLESTJQOEHIBLM
|
6.6 | IC50 | 2 | — | |
STEGBXHZVWLLAP
|
6.6 | IC50 | 6 | — | |
BRZYOTMFHLERHD
|
6.5 | Ki | 17 | Yes | |
RSTWARDIGORXQU
|
6.5 | Ki | 5 | Yes | |
DKHPQQRGPHOKBV
|
6.5 | IC50 | 3 | — | |
OVJZHEDXGAPGDA
|
6.5 | IC50 | 3 | — | |
OVJZHEDXGAPGDA
|
6.5 | IC50 | 5 | — | |
VREDQQFDKBEALJ
|
6.5 | IC50 | 5 | — | |
LGZGODIORQOSNB
|
6.5 | IC50 | 5 | — | |
MDRQBBNTQCZOBR
|
6.5 | IC50 | 6 | — | |
MDRQBBNTQCZOBR
|
6.5 | IC50 | 6 | — | |
WMWXMWABKUQJNC
|
6.5 | IC50 | 3 | — | |
XNKIVXYFRPYKHO
|
6.5 | IC50 | 12 | Yes | |
KLTAXINXABHYMC
|
6.5 | IC50 | 5 | — | |
TVIALAOHRQNPOI
|
6.5 | IC50 | 12 | Yes | |
GEWLYFZWVLXQME
|
6.5 | IC50 | 9 | — | |
VUZOCQCFKZJNJC
|
6.5 | IC50 | 5 | — | |
FSPDDRAYNYPNIF
|
6.5 | IC50 | 2 | — | |
FSPDDRAYNYPNIF
|
6.5 | IC50 | 2 | — | |
JOOTZGPUMCZHLH
|
6.5 | IC50 | 5 | — | |
DKOCZDDCSUQYTF
|
6.5 | IC50 | 5 | — | |
QYEKPILGAVXHQH
|
6.5 | IC50 | 2 | — | |
QYEKPILGAVXHQH
|
6.5 | IC50 | 5 | — | |
HPCPUHOULFPBCQ
|
6.5 | IC50 | 12 | Yes | |
JDZXLEPJWLCESI
|
6.5 | IC50 | 12 | Yes | |
RHBWAFDCVFMIFK
|
6.5 | IC50 | 12 | Yes | |
RPLXVENRWORMRX
|
6.4 | IC50 | 12 | Yes | |
LQESNGDPCQOCKO
|
6.4 | IC50 | 2 | — | |
YUJAAMQBNNAQRP
|
6.4 | IC50 | 6 | — | |
BMGQWWVMWDBQGC
|
6.4 | IC50 | 147 | Yes | |
MQFYZWYYZGTHAN
|
6.4 | IC50 | 14 | — | |
HHLKZSJXDAZIGG
|
6.4 | IC50 | 10 | Yes | |
CIVFNZIOXQANAM
|
6.4 | IC50 | 5 | — | |
HRJWTAWVFDCTGO
|
6.4 | IC50 | 13 | Yes | |
KAJXOWFGKYKMMZ
|
6.4 | IC50 | 26 | Yes | |
ASUGUQWIHMTFJL
|
6.4 | Kd | 18 | — | |
MVPSDKPPZLPMBB
|
6.4 | Ki | 7 | Yes | |
XDTAJQIDTGQFQG
|
6.4 | IC50 | 3 | — | |
ZFNQOYBHHLGQDV
|
6.3 | IC50 | 12 | Yes | |
FURJAMJXUHRQFZ
|
6.3 | IC50 | 3 | — |